Study of Oral Uremic Toxin Absorbent/Probiotics to Modulate Systemic Inflammation and Retard the Progression of Chronic Kidney Disease in Patients With Diabetes.
Clinical trial NCT07333313 · RECRUITING
Trial details
- NCT number
- NCT07333313
- Sponsor
- National Taiwan University Hospital
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-31
- Primary completion
- 2029-03-31
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.